Artículos con órdenes de acceso público - Sean Micheal O'CathailMás información
No disponibles en ningún lugar: 2
Intravenous versus oral dexamethasone premedication in preventing Paclitaxel infusion hypersensitivity reactions in gynecological malignancies
SM O’Cathail, R Shaboodien, S Mahmoud, K Carty, P O’Sullivan, ...
International Journal of Gynecologic Cancer 23 (7), 2013
Órdenes: Cancer Research UK
A multicentre retrospective review of SABR reirradiation in rectal cancer recurrence
P Johnstone, L Okonta, K Aitken, J Holmes, M Harrison, D Harji, ...
Radiotherapy and Oncology 162, 1-6, 2021
Órdenes: Cancer Research UK
Disponibles en algún lugar: 27
Drug radiotherapy combinations: review of previous failures and reasons for future optimism
GS Higgins, SM O’Cathail, RJ Muschel, WG McKenna
Cancer Treatment Reviews 41 (2), 105-113, 2015
Órdenes: Cancer Research UK, UK Medical Research Council
CRISPR-Cas9 causes chromosomal instability and rearrangements in cancer cell lines, detectable by cytogenetic methods
E Rayner, MA Durin, R Thomas, D Moralli, SM O'cathail, I Tomlinson, ...
The CRISPR journal 2 (6), 406-416, 2019
Órdenes: UK Medical Research Council, Wellcome Trust
An inflammation based score can optimize the selection of patients with advanced cancer considered for early phase clinical trials
DJ Pinato, C Stavraka, MJ Flynn, MD Forster, SM O'Cathail, MJ Seckl, ...
PloS one 9 (1), e83279, 2014
Órdenes: Cancer Research UK, Wellcome Trust
Combining oncolytic adenovirus with radiation—a paradigm for the future of radiosensitization
SM O’Cathail, TD Pokrovska, TS Maughan, KD Fisher, LW Seymour, ...
Frontiers in oncology 7, 153, 2017
Órdenes: Cancer Research UK, UK Medical Research Council
Initial results from the Royal College of Radiologists' UK national audit of anal cancer radiotherapy 2015
R Muirhead, K Drinkwater, SM O'Cathail, R Adams, R Glynne-Jones, ...
Clinical Oncology 29 (3), 188-197, 2017
Órdenes: Cancer Research UK
A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally …
SM O’Cathail, S Davis, J Holmes, R Brown, K Fisher, L Seymour, ...
Radiation Oncology 15, 1-8, 2020
Órdenes: Cancer Research UK, UK Medical Research Council
Developing an objective marker to optimize patient selection and predict survival benefit in early‐phase cancer trials
C Stavraka, DJ Pinato, SJ Turnbull, MJ Flynn, MD Forster, SM O'Cathail, ...
Cancer 120 (2), 262-270, 2014
Órdenes: Cancer Research UK
Intensity-modulated radiotherapy for rectal cancer in the UK in 2020
CR Hanna, F Slevin, A Appelt, M Beavon, R Adams, C Arthur, M Beasley, ...
Clinical Oncology 33 (4), 214-223, 2021
Órdenes: Cancer Research UK, UK Medical Research Council, National Institute for …
Activity of eribulin mesylate in heavily pretreated breast cancer granted accessvia the Cancer Drugs Fund
R Ramaswami, SM O ‘Cathail, JH Brindley, P Silcocks, S Mahmoud, ...
Future Oncology 10 (3), 363-376, 2014
Órdenes: Cancer Research UK
NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer
SM O'Cathail, CH Wu, A Lewis, C Holmes, MA Hawkins, T Maughan
Cancer Genetics 248, 1-10, 2020
Órdenes: Cancer Research UK, UK Engineering and Physical Sciences Research Council …
Stereotactic body radiation therapy reirradiation for locally recurrent rectal cancer: outcomes and toxicity
T Smith, SM O’Cathail, S Silverman, M Robinson, Y Tsang, M Harrison, ...
Advances in Radiation Oncology 5 (6), 1311-1319, 2020
Órdenes: Cancer Research UK, UK Medical Research Council, National Institute for …
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)
CR Hanna, SM O’Cathail, JS Graham, M Saunders, L Samuel, M Harrison, ...
Radiation Oncology 16, 1-9, 2021
Órdenes: Cancer Research UK
NRF2 mediates therapeutic resistance to chemoradiation in colorectal cancer through a metabolic switch
SM O’Cathail, CH Wu, R Thomas, MA Hawkins, TS Maughan, A Lewis
Antioxidants 10 (9), 1380, 2021
Órdenes: Cancer Research UK, UK Medical Research Council, National Institute for …
Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: Initial outcomes
R Cooke, P Camilleri, KY Chu, SM O'Cathail, M Robinson, ...
Technical Innovations & Patient Support in Radiation Oncology 13, 24-30, 2020
Órdenes: Cancer Research UK, UK Medical Research Council
Update on neoadjuvant regimens for patients with operable oesophageal/gastrooesophageal junction adenocarcinomas and squamous cell carcinomas
SJ Cox, SM O’Cathail, B Coles, T Crosby, S Mukherjee
Current oncology reports 19, 1-11, 2017
Órdenes: Cancer Research UK
Superior outcomes of nodal metastases compared to visceral sites in oligometastatic colorectal cancer treated with stereotactic ablative radiotherapy
SM O'Cathail, T Smith, R Owens, A Zeniou, Y Tsang, DLP Holyoake, ...
Radiotherapy and Oncology 151, 280-286, 2020
Órdenes: Cancer Research UK, UK Medical Research Council, National Institute for …
Challenges and consequences of COVID-19 in the management of anorectal cancer: coming together through social distancing
SM O'Cathail, DC Gilbert, D Sebag-Montefiore, R Muirhead
Clinical Oncology 32 (7), 413-416, 2020
Órdenes: Cancer Research UK
The impact of COVID-19 on radiotherapy services in Scotland, UK: a population-based study
L Grocutt, A Rutherford, D Caldwell, C Wilkinson, AJ Chalmers, ...
Clinical Oncology 35 (2), e227-e234, 2023
Órdenes: Cancer Research UK
La información de publicación y financiación se determina de forma automática mediante un programa informático